Asthma forward secondary graphic Asthma forward secondary graphic

Unmet needs

Asthma remains a serious health risk in the US1. In this section you will find information on the unmet need for more effective asthma treatments for the many patients still experiencing burdensome symptoms despite ICS/LABA treatment.

Podcasts

Podcast graphic

What are the key considerations for managing patients with uncontrolled asthma?

Asthma is a heterogeneous disease and its management is multifactorial; many patients often remain uncontrolled despite treatment…

Find Out More

Podcast graphic

Which treatments should be considered when patients have inadequately controlled asthma on ICS/LABA?

More effective asthma treatments are needed as many patients still experience burdensome symptoms despite ICS/LABA treatment1-5...

Find Out More

Webinars

Webinar graphic

What are the long-term goals of asthma management?

The long-term goals of asthma management are to achieve…

Find Out More

Posters

Poster graphic

JRS 2023: The impact of not well controlled versus well controlled asthma on patients’ daily lives in Japan

The 63rd Annual Meeting of the Japanese Respiratory Society took place 28–30 April 2023 in Tokyo, Japan.

Find Out More

Reference

  1. Centers for Disease Control and Prevention (CDC). Most recent national asthma data. Last updated March 24, 2020. Accessed June 12, 2020.

Asthma Forward is a registered trade mark of the GSK group of companies.
©2023 GSK group of companies. All rights reserved.

SE-GBL-FVU-WCNT-200002 | Date of preparation: April 2023